M. W. Büchler

Prophylactic Glycine Administration Attenuates Pancreatic Damage and Inflammation in Experimental Acute Pancreatitis

H. Friess, M. Büchler, J. Mayerle, 2011, Pancreatology.

Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases.

R Krempien, F A Calvo, C. V. D. van de Velde, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Simultaneous pancreas–kidney transplantation in type 1 diabetes

J. Weitz, A. Mehrabi, M. Zeier, 2004, Clinical transplantation.

Met-enkephalin-like immunoreactivity in Merkel cells

E. Weihe, W. Forssmann, M. Büchler, 1979, Cell and Tissue Research.

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

C. von Kalle, C. Heining, H. Glimm, 2008, BMC Cancer.

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

R. Krempien, H. Knaebel, H. Schmitz‐Winnenthal, 2005, BMC Cancer.

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

V. Diehl, H. Goldschmidt, U. Mansmann, 2005, BMC Cancer.

Comparison of Venae Sectio vs. modified Seldinger Technique for Totally Implantable Access Ports; Portas-trial [ISRCTN:52368201]

P. Kienle, H. Knaebel, M. Buchler, 2006, Trials.

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

V. Diehl, H. Goldschmidt, U. Mansmann, 2005, BMC Cancer.